Form D · Pharmaceuticals
CRITITECH INC
Lawrence, KS · CIK 0001142024
Offering snapshot reported Jan 18, 2013 · SEC filing
- Reported sold
- $3M Offering amount: $6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $3M Reported outside-investor minimum
- First sale
- Mar 20, 2012 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 18, 2013 | Amendment | $3,000,000 | $0vs Apr 2, 2012 | 1 | SEC filing |
| Jan 18, 2013 | Amendment | $1,183,000 | $1,153,000vs Jun 28, 2011 | 20 | SEC filing |
| Jul 18, 2012 | Amendment | $718,000 | $688,000vs Jun 28, 2011 | 12 | SEC filing |
| Apr 2, 2012 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Jun 28, 2011 | Initial | $30,000 | No comparison | 1 | SEC filing |
| May 6, 2010 | Initial | $60,000 | No comparison | 1 | SEC filing |
| Dec 10, 2009 | Initial | $1,050,000 | No comparison | 7 | SEC filing |
| Dec 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 28, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 22, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-176029
$3,000,000 payable in six installments
Source: Form D, filed Jan 18, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sam D Campbell | Director, Executive |
| William P Duncan | Director |
| Joe Fix | Director |
| David Johnston | Director, Executive |
| Matthew Mc Clorey | Director, Executive |
| Jeffrey Morrison | Executive |
| Francois Sauer | Director |
| Bala Subramaniam | Director |
| Michele Weigand | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Lawrence, KS, 66044